Special Role of Foxp3 for the Specifically Altered MicroRNAs in Regulatory T Cells of HCC Patients

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2014 Jul 9

PMID 25000974

Citations 13

Authors

Long Chen

Huiying Ma

Heng Hu

Lingling Gao

Xuan Wang

Jiaqi Ma

Qiang Gao

Binbin Liu

Guomin Zhou

Chunmin Liang

Affiliations

Soon will be listed here.

Abstract

Background: Regulatory T cells (Tregs) exhibit functional abnormalities in the context of hepatocellular carcinoma (HCC). The microRNAs (miRNAs) are identified as the key modulators in Tregs. This study was to explore whether the expression profiles of miRNAs of Tregs were different in HCC-activated Tregs and whether Foxp3 had special effects on them.

Methods: We isolated HCC-activated Tregs from mice bearing HCC and compared the expression profiles of miRNAs between HCC-activated Tregs and control Tregs by microarray. RNA interference against Foxp3 was also performed through transfection of synthetic siRNAs to Tregs for analyzing the effect of Foxp3 on the expression of miRNAs. Tregs isolated from HCC patients (n = 12) and healthy controls (n = 7) were used for validation of the differentially expressed miRNAs. Finally, bioinformatic analysis was applied to infer their possible roles.

Results: We found nine specifically altered miRNAs in HCC-activated Tregs from the murine model. After transfection with siRNAs against Foxp3, control Tregs showed obvious reduction of Foxp3 and five miRNAs were significantly changed; HCC-activated Tregs exhibited a slight reduction of Foxp3 with three miRNAs significantly changed. Tregs from HCC patients and healthy controls finally confirmed the up-regulation of four miRNAs (hsa-miR-182-5p, hsa-miR-214-3p, hsa-miR-129-5p and hsa-miR-30b-5p). Following bioinformatic analysis suggested these altered miRNAs would target eight important signaling pathways that could affect the functions of Tregs.

Conclusions: Our studies provided the first evidence that Tregs in HCC had the specifically altered expression of miRNAs, which was affected by Foxp3. These results are useful both in finding new biomarkers and in further exploring the functions of Tregs in HCC patients.

Citing Articles

Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy.

Wang L, Wang J, Xu A, Wei L, Pei M, Shen T J Nanobiotechnology. 2024; 22(1):472.

PMID: 39118155 PMC: 11312222. DOI: 10.1186/s12951-024-02633-y.

MicroRNAs: immune modulators in cancer immunotherapy.

Xing Y, Wang Z, Lu Z, Xia J, Xie Z, Jiao M Immunother Adv. 2022; 1(1):ltab006.

PMID: 35919742 PMC: 9327120. DOI: 10.1093/immadv/ltab006.

Systematic Understanding of the Mechanism of Baicalin against Gastric Cancer Using Transcriptome Analysis.

Zhou W, Gao M, Liang C, Lin B, Wu Q, Chen R Biomed Res Int. 2021; 2021:5521058.

PMID: 34337018 PMC: 8315853. DOI: 10.1155/2021/5521058.

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.

Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T Cancers (Basel). 2021; 13(3).

PMID: 33572780 PMC: 7866004. DOI: 10.3390/cancers13030514.

Upregulated miRNA-182-5p expression in tumor tissue and peripheral blood samples from patients with non-small cell lung cancer is associated with downregulated Caspase 2 expression.

Yang L, Dou Y, Sui Z, Cheng H, Liu X, Wang Q Exp Ther Med. 2020; 19(1):603-610.

PMID: 31897103 PMC: 6923754. DOI: 10.3892/etm.2019.8074.

References

Zheng Y, Chaudhry A, Kas A, deRoos P, Kim J, Chu T . Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 2009; 458(7236):351-6. PMC: 2864791. DOI: 10.1038/nature07674. View

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Cong Y, Feng T, Fujihashi K, Schoeb T, Elson C . A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A. 2009; 106(46):19256-61. PMC: 2780781. DOI: 10.1073/pnas.0812681106. View

Chaudhry A, Rudra D, Treuting P, Samstein R, Liang Y, Kas A . CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 2009; 326(5955):986-91. PMC: 4408196. DOI: 10.1126/science.1172702. View

Gao Q, Qiu S, Fan J, Zhou J, Wang X, Xiao Y . Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007; 25(18):2586-93. DOI: 10.1200/JCO.2006.09.4565. View

Yadav M, Huang M, Goetzl E . VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. Cell Immunol. 2011; 267(2):124-32. DOI: 10.1016/j.cellimm.2011.01.001. View

Zhou J, Ding T, Pan W, Zhu L, Li L, Zheng L . Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int J Cancer. 2009; 125(7):1640-8. DOI: 10.1002/ijc.24556. View

Paquette J, Tokuyasu T . EGAN: exploratory gene association networks. Bioinformatics. 2009; 26(2):285-6. PMC: 2804305. DOI: 10.1093/bioinformatics/btp656. View

Wang H, Wang R . Regulatory T cells and cancer. Curr Opin Immunol. 2007; 19(2):217-23. DOI: 10.1016/j.coi.2007.02.004. View

10.

Divekar A, Dubey S, Gangalum P, Singh R . Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol. 2010; 186(2):924-30. PMC: 3038632. DOI: 10.4049/jimmunol.1002218. View

11.

Bronevetsky Y, Villarino A, Eisley C, Barbeau R, Barczak A, Heinz G . T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J Exp Med. 2013; 210(2):417-32. PMC: 3570096. DOI: 10.1084/jem.20111717. View

12.

Eikawa S, Ohue Y, Kitaoka K, Aji T, Uenaka A, Oka M . Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol. 2010; 185(11):6734-40. DOI: 10.4049/jimmunol.1000225. View

13.

Chen K, Lin S, Zhou L, Xie H, Zhou W, Taki-Eldin A . Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One. 2011; 6(9):e24671. PMC: 3173477. DOI: 10.1371/journal.pone.0024671. View

14.

Xiao C, Rajewsky K . MicroRNA control in the immune system: basic principles. Cell. 2009; 136(1):26-36. DOI: 10.1016/j.cell.2008.12.027. View

15.

Yang X, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H . Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol. 2006; 45(2):254-62. DOI: 10.1016/j.jhep.2006.01.036. View

16.

Ohkura N, Sakaguchi S . Treg cells acquire new directions, cytokines navigate. Immunity. 2012; 37(3):443-4. DOI: 10.1016/j.immuni.2012.09.004. View

17.

Lu L, Boldin M, Chaudhry A, Lin L, Taganov K, Hanada T . Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010; 142(6):914-29. PMC: 3049116. DOI: 10.1016/j.cell.2010.08.012. View

18.

Liston A, Lu L, OCarroll D, Tarakhovsky A, Rudensky A . Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med. 2008; 205(9):1993-2004. PMC: 2526195. DOI: 10.1084/jem.20081062. View

19.

Yang P, Li Q, Feng Y, Zhang Y, Markowitz G, Ning S . TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 2012; 22(3):291-303. PMC: 3443566. DOI: 10.1016/j.ccr.2012.07.023. View

20.

Takata Y, Nakamoto Y, Nakada A, Terashima T, Arihara F, Kitahara M . Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma. Cancer Lett. 2011; 307(2):165-73. DOI: 10.1016/j.canlet.2011.03.029. View